Kura Oncology, Inc.
Current role
KURA
Francis Burrows, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Francis Burrows, Ph.D.
Kura Oncology, Inc. reported in an 8-K filed January 6, 2025 that Francis Burrows, Ph.D. was appointed Chief Scientific Officer, effective January 2, 2025.
“On January 2, 2025, the Company appointed (i) Mollie Leoni, M.D. as its Chief Medical Officer and (ii) Francis Burrows, Ph.D. as its Chief Scientific Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Kura Oncology, Inc. (KURA)
SEC 8-K
Current2025-01-02–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kura Oncology, Inc.
Other people whose current roles at this company are on record from its filings.
- Troy Wilson CEO
- Jennifer Fulk CFO
- Troy E. Wilson, Ph.D., J.D. CFO, Board Member
- Kathleen Ford COO
- Thomas Doyle Chief Accounting Officer
- Carol A. Schafer Board Member
- Carol Schafer Board Member
- Diane Parks Board Member
- Faheem Hasnain Board Member
- Helen Collins, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.